These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
384 related articles for article (PubMed ID: 30718356)
41. Insights Into the Molecular and Cellular Underpinnings of Cutaneous T Cell Lymphoma. Yumeen S; Girardi M Yale J Biol Med; 2020 Mar; 93(1):111-121. PubMed ID: 32226341 [TBL] [Abstract][Full Text] [Related]
42. Transcriptome sequencing in Sezary syndrome identifies Sezary cell and mycosis fungoides-associated lncRNAs and novel transcripts. Lee CS; Ungewickell A; Bhaduri A; Qu K; Webster DE; Armstrong R; Weng WK; Aros CJ; Mah A; Chen RO; Lin M; Sundram U; Chang HY; Kretz M; Kim YH; Khavari PA Blood; 2012 Oct; 120(16):3288-97. PubMed ID: 22936659 [TBL] [Abstract][Full Text] [Related]
43. Genome-wide transcriptome analysis of the STAT6-regulated genes in advanced-stage cutaneous T-cell lymphoma. Gaydosik AM; Queen DS; Trager MH; Akilov OE; Geskin LJ; Fuschiotti P Blood; 2020 Oct; 136(15):1748-1759. PubMed ID: 32438399 [TBL] [Abstract][Full Text] [Related]
44. Analysis of clonality in cutaneous T cell lymphoma and associated diseases. Wood GS Ann N Y Acad Sci; 2001 Sep; 941():26-30. PubMed ID: 11594579 [TBL] [Abstract][Full Text] [Related]
45. Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma. Vidulich KA; Talpur R; Bassett RL; Duvic M Int J Dermatol; 2009 Mar; 48(3):243-52. PubMed ID: 19261011 [TBL] [Abstract][Full Text] [Related]
46. FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival. Gjerdrum LM; Woetmann A; Odum N; Burton CM; Rossen K; Skovgaard GL; Ryder LP; Ralfkiaer E Leukemia; 2007 Dec; 21(12):2512-8. PubMed ID: 17713545 [TBL] [Abstract][Full Text] [Related]
47. Loss of BCL7A expression correlates with poor disease prognosis in patients with early-stage cutaneous T-cell lymphoma. Litvinov IV; Zhou Y; Kupper TS; Sasseville D Leuk Lymphoma; 2013 Mar; 54(3):653-4. PubMed ID: 22856870 [No Abstract] [Full Text] [Related]
48. Plasma miR-155, miR-203, and miR-205 are Biomarkers for Monitoring of Primary Cutaneous T-Cell Lymphomas. Dusílková N; Bašová P; Polívka J; Kodet O; Kulvait V; Pešta M; Trněný M; Stopka T Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036928 [TBL] [Abstract][Full Text] [Related]
50. Evaluation, Diagnosis, and Staging of Cutaneous Lymphoma. Olsen EA Dermatol Clin; 2015 Oct; 33(4):643-54. PubMed ID: 26433839 [TBL] [Abstract][Full Text] [Related]
51. Identification of tyrosine kinase, HCK, and tumor suppressor, BIN1, as potential mediators of AHI-1 oncogene in primary and transformed CTCL cells. Kennah E; Ringrose A; Zhou LL; Esmailzadeh S; Qian H; Su MW; Zhou Y; Jiang X Blood; 2009 May; 113(19):4646-55. PubMed ID: 19211505 [TBL] [Abstract][Full Text] [Related]
52. New perspectives in experimental and clinical research for cutaneous T cell lymphomas. Burg G; Häffner A; Böni R; Dommann S; Dummer R Recent Results Cancer Res; 1995; 139():225-37. PubMed ID: 7597294 [TBL] [Abstract][Full Text] [Related]
53. The Use of Transcriptional Profiling to Improve Personalized Diagnosis and Management of Cutaneous T-cell Lymphoma (CTCL). Litvinov IV; Netchiporouk E; Cordeiro B; Doré MA; Moreau L; Pehr K; Gilbert M; Zhou Y; Sasseville D; Kupper TS Clin Cancer Res; 2015 Jun; 21(12):2820-9. PubMed ID: 25779945 [TBL] [Abstract][Full Text] [Related]